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Variously aged (C57BL X C3H)F1 hybrid mice were used
as recipients in experiments to determine if spleen or
bone marrow cells from normal C57BL or C3H donors, spleen
or bone marrow cells from C57BL donors previously treated
with cortisone, or C57BL bone marrow cells previously incu-
bated with serum from X-irradiated C57BL mice could induce
a graft-versus-host reaction (GVHR).
The mice were assayed for GVHR by mortality or spleno-
megaly as detected by the discriminant spleen assay developed
by Simonsen. Results show that spleen cells from normal
C57BL, normal C3H, or cortisone-treated C57BL mice are
capable of inducing a GVHR in Fi hybrids, resulting in death
or splenomegaly, whereas bone marrow cells from normal C3H,
normal C57BL, or cortisone-treated C57BL mice were unable to
induce a GVHR in F
1 
hybrids. It was also found that sera
from lethally irradiated C57BL mice did not cause C57BL





When cells and tissues are grafted into an animal with
a different genotype, one of two phenomena may occur:
the host may react against the graft, eventually rejecting
it in a typical host-versus-graft reaction or, if the host
is immunotolerant and the graft is immunocompetent and re-
cognizes the antigens of the host as foreign, the graft may
reject the host in a typical graft-versus-host reaction
(GVHR).
The GVHR has been found in newborn mice grafted with
adult allogeneic spleen cells (1,2,3), in newborn F1 hybrids
grafted with parental spleen cells (4-9), and in animals given
various immunosuppressive treatments (10). A few signs of a
GVHR include death of the host (1,2,11), runting (growth
inhibition and emaciation) (1,2,11), splenomegaly (1,2,8,9,
11), immune hemolytic anemia (1,11), diarrhea (1,11), severe
dermatitis and hair loss (1), and suppression of mitosis (12).
The magnitude and strength of the GVHR depend upon both
the age and the genetic difference between the donor and the
host. The greatest GVHRs have been obtained with F1 hybrids
young enough to be immunotolerant (1,2,3). Immunocompetent
spleen cells from donors older than 5 days have been shown
capable of eliciting a GVHR (13,14). The most severe GVHR
1
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was noted when donor and recipient mice differed at the
major histocompatability locus, the H-2 locus (2,15-17), and
a GVHR resulted 100 percent of the time when donor and
recipient mice differed at the 11-2 locus (15).
The extreme effect of the GVHR is the death of the host.
Intensive searches yielded no bacterial, fungal, or parasitic
contaminants from animals that died from a GVHR (1). These
findings suggest that the GVHR is the result of an immuno-
logical reaction (1,2).
It has been shown that bone marrow cells taken from
donors which were injected with cortisone prior to being killed
were capable of mounting a GVHR (18). It was postulated
that cortisone destroys cells which are not involved in the
GVHR and causes a movement of spleen cells capable of mounting
a GVHR to enter the bone marrow (18).
The work reported in this thesis was initiated to
determine: (i) the ability of parental spleen or bone marrow
cells to provoke a GVHR in F1 hybrids, (ii) the ability of
spleen or bone marrow cells from cortisone-treated mice of
the C57BL parental strain to induce a GVHR in F
1 
hybrids,
and (iii) if there exists a factor in sera oi irradiated
animals which modifies the behavior of bone marrow cells
when grafted into F1 hybrids.
MATERIALS AND METHODS





), both male and female, were obtained from Cumberland
View Farms, Clinton, Tennessee. These strains were pro-
pagated and used to produce (C57BL x C3H)F1 
hybrids as
needed. The mice were housed in polypropylene cages con-
taining a 5-cm layer of 1/8-in ground cob bedding (Andersons
Cob Division, Maumee, Ohio) which was changed weekly. They
were provided Laboratory Chow (Ralston Purina Company, St.
Louis, Missouri) and water ad libitium.
Cell suspensions. Suspensions of spleen cells were
prepared by mincing the organ with scissors and pressing
the slices through a 80-mesh brass screen by means of a
glass plunger from a 2-cc syringe while the cells were con-
stantly bathed in cold RPMI-1640 (Grand Island Biological
Company, Grand Island, New York) tissue culture medium
supplemented with a commercial penicillin-streptomycin mix-
ture (Grand Island Biological Company, Grand Island, New
York) in the amounts of 100 units of penicillin and 100 ug
of streptomycin per ml.
Suspensions of bone marrow cells were prepared by
flushing the marrow from freshly excised femurs with cold




All suspensions of cells were transported in centrifuge
tubes in ice to an IEC Pr-J centrifuge (Damon/IEC Division,
Needham Heights, Massachusetts) and centrifuged at 1000 rpm
at 4° C for 10 min. The supernatants were discarded and the
pellet of cells was resuspended in fresh, cold RPMI-1640.
The cell populations were determined with a hemocytometer by
diluting a sample of cells to one in one hundred with a 2
percent acetic acid solution and counting in a Levy counting
chamber. The cell count was determined and adjusted to the
desired concentration with cold RPMI-1640. Various concen-
trations of cells in volumes between 3.1 and 0.2 ml were
injected intraperitoneally (i.p.) into the F1 hybrids.
Assay of the GVHR. The GVHR was induced by giving the
F
1 
hybrids a specified dose of parental spleen or bone marrow
cells. Ten days after the injection the amount of the GVHR
was assayed by the Simonsen method (1). This method in-
volves determining the relative spleen weight (RSW) for each
of the F
1 
hybrids. This is done by dividing the weight of
spleen in mg by the body weight of the animal in g. The
RSW is then used to determine the spleen index. The spleen
indices are calculated by dividing the average RSW of the
animals which received the test cells by the average RSW
of the designated control group. A spleen index greater
than 1.30 was assumed to be indicative of a GVHR.
Cortisone preparation and iniection. The cortisone
suspension used was prepared by adding 250 mg of cortisone
acetate (Nutritional Biochemicals Company, Cleveland, Ohio)
5
to 100 ml of sterile physiological saline. Appropriate
dosages of 0.5 ml were injected i.p. with a 1-cc syringe
fitted with a 27.5- a needle.
Irradiation of mice. The X-irradiation of the mice
was done with a General Electric X-ray unit (model number
42 Type 1). The unit was set for 10 ma and 175 kvp. Each
mouse was placed in a specially modified 50-ml Corning
screwcapped centrifuge tube (Corning, New York). The tulL
was fastened onto a revolving turntable which was located
30 cm directly under the camera of the X-ray unit to assure
homogeneity of exposure. A 0.5-mm thick copper plate was
used for shielding. A delivery rate was determined by means
of a model 35020 dosimeter (Keithley Instruments Inc.,
Cleveland, Ohio) to be 36 r/min.
Bleeding of the mice and serum collection. The mice
were heated with a heat lamp for approximately one min
in a closed container. Upon heating, a tail vein of the
mouse was severed with a razor blade and blood was collected
into a 10- x 75-mm Pyrex test tube. The blood was incubated
for 1 hr at 37° C and allowed to clot. The blood clot was
removed and the blood was centrifuged for 10 min in an IEC
clinical centrifuge (Damon/IEC Division, Needham Hts.,
Massachusetts) at a setting of 7. After centrifugation, the
serum was transferred via a 9-in pasteur pipet into a 6- x
50-mm test tube and stored at 4
0
 C until needed.
Incubation of the parental bone marrow cells withL
normal or irradiated sera from C57BL mice. One ml of a
6
suspension of bone marrow cells was placed into a 4-cm
diar er glass petri dish containing sera from X-irradiated
or normal C57BL mice dilutet_. 1:4 (v/v) in RPMI-1640 tissue
culture medium supplemented with penicillin (100 units/m1),
streptomycin (100 g/m1), and 5% (v/v) of fetal bovine
serum (Grand Island Biological Company, Grand Island, New
York). The petri dishes were then covered and incubated at
37
0 
C for 1 hr. The cells were cilen transferred to an iced
centrifuge tube, pelleted by 10 min of centrifugation at
1000 rpm at 40 C, resuspended in fresh RPMI-1640 tissue
culture medium, counted, and diluted with RPMI-1640 tissue
culture medium to yield a suspension containing 2 x 10
8 
cells
per ml. Twenty million C57BL bone marrow cells which had
been incubated with serum from X-irradiated donors were
injected i.p. into each of 6 mice. Each of eight mice was
similarly given 2 x 107 C57BL bone marrow cells that had




hybrids grafted with C57BL bone marrow
or spleen cells. An experiment was performed to determine
the mortality rate of F1 hybrids as a result of a GVHR
initiated by parental spleen or bone marrow cells.
Twenty million C57BL spleen or bone marrow cells were
injected i.p. into each mouse in 6 litters of 10-day-old
(C57BL X C3H)F1 hybrids. Eighteen mice were challenged with
parental C57BL spleen cells and 15 mice were challenged with
parental C57BL bone marrow cells. The litters were checked
daily for dead animals. The time of death was determined
from the time of injection of the parental cells.
The results are shown in Figure 1. The results show
that parental spleen cells induced mortality in the F1
hybrids whereas bone marrow cells did not. Signs prior to
death of the mice were dwarfness, hair loss, and diarrhea,
which are major signs of a GVHR. Mortality induced by
parental spleen cells was initiated at day 13, and was 100
percent by day 57. The 50'70- mortality point was found to
be 22 days.
Spleen indices of F
1 
hybrids grafted with parental bone
marrow or spleen cells. An experiment was performed to
determine if parental bone marrow or spleen cells could
induce a GVHR as detected by the Simonsen assay.
7
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Six- to 10-day-old (C57BL x C311)F1 hybrids were in-
jected i.p. with varic amounts of either parental strain
spleen or bone marrow cells, RPMI-1640, or nothing. An
average RSW was calculated according to Simonsen (1) for
each particular designated group ten days after the injec-
tion of the test cells.
The results are seen in Table 1. Groups A and B show
the RSW of the controls used in these experiments. Spleen
indices of groups C and D show that a GVHR occurs with any
dose of spleen cells used from either parent, whereas those
of groups E, F, and G are less than 1.30, indicating that no
GVHR has occurred. The results indicate that the grafting
cf spleen cells from either parent into (C57BL X C311)F1
hybrid mice causes a GVHR but bone marrow does not.
The effect of cortisone treatment on bone marrow and
spleen cells. An experiment was performed to find out if
cortisone treatment of donors of parental bone marrow cells
could render those cells capable of inducing a GVHR when
grafted into (C57BL X C3H)F
1 
hybrids.
A group of C57BL donors was given two i.p. injections
of a cortisone suspension, one at 36 hr and another at 24 hr
prior to killing. A total dose of 2.5 mg of cortisone was
given to each donor. Various amounts of bone marrow and spleen
cells from cortisone-treated and normal C57BL mice were in-
jected i.p. into F
1 
hybrids of various ages. Ten days later
the spleen indices were determined according to Simonsen (1).
TABLE I
Ability of parental bone marrow or spleen cells to cause
a GVHR
a




Group Donor Type Number of mice Average - SD SI
dc
A None - - 9 5.68 I 2.0
+
B RPMI-1640 - - 8 5.66 - 1.5 1.00











D C57BL L'pleen 1-2 x 10' 5 21.25 - 1.9 3.74






F C57BL Marrow 1-2 x 10
7
10 5.46 - 0.8 0.96





Relative spleen weight determined according to Simonsen (1).
Standard deviation.
Spleen index determined according to Simonsen (1).
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The results are seen in Table 2. The spleen indices
show that when spleen cells from normal or cortisone-treated
C57BL mice are injected into F1 hybrids 23 days old or less a
GVHR occurs, but if the recipient F1 hybrids are 26 to 27
days old the spleen indices indicate that no GVHR occurs.
Table 2 also shows that the grafting of bone marrow from
normal or cortisone-treated C57BL mice into any age F1 hybrid
did not produce a GVHR.
The effect of incubation of serum from irradiated or
normal C57BL mice with C57BL bone marrow cells. An experi-
ment was designed to ascertain the possible existence of a
mouse serum factor rendering bone marrow capable of inducing
a GVHR. Bone marrow cells from C57BL parental mice were
incubated for 1 hr at 37
0
 C in the presence of pooled
syngeneic serum, diluted 1:4 (v/v) in RPMI-1640 tissue
culture medium, from either normal mice or mice that had
been given 865 r of X radiation 3 days prior to being
bled. The serum-incubated cells were injected i.p. into
appropriate groups of 9- to 11-day-old mice which were sac-
rificed 10 days following the injection and their spleen
indices were determined according to Simonsen (1)
The results are seen in Table 3. The (C57BL x C3H)F
1
hybrids that were injected with C57BL bone marrow cells which
were previously incubated with serum from lethally irradiated
C5713L mice show a spleen index of 1.09, which indicates no
GVHR has taken place.
TABLE II
Ability of parental bone marrow or spleen cells from nornial or cortisone-treated
C57BL mice to cause a GVHR in (C57BL x C3H)F hybrids















I Normal bone marrow 14 4 x 107 5.39 0.94
J Normal bone marrow 32 2 x 107 6.64 1.16
+
K Cortisone-treated marrow 9-10 1-2 x 10
7
6.15 - 2.9 1.08
L Cortisone-treated marrow 14 4 x 10
7
5.87 1.03
M Cortisone-treated narrow 32 2 x 10
7
4.99 0.87





C Normal spleen 23 1.5 x 10
7
12.12 2.13










R Cortisone-treated spleen 23 1.5 x 10
7
11.02 1.94







Relative spleen weights were calculated according to Simonsen (1) ten days after injection.
Standard deviation.
d 
Spleen index calculated according to Simonsen (1).
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TABLE III
The effect of sera from lethalli X-irradiated mice
Ilpon the ability of syngeneic bone marrow cells










C57BL mice 6 7.11 - 0.98
Serum from lethally
X-irradiated C57BL mice 8 7.72 - 1.05 1.09
a
One ml
8of C57BL bone marrow cells at the concentration of
2 x 10 cells/ml was incubated for 1 hr at 37
o 
C with an
equal volume of treatment serum. The treatment serum
consisted of pooled syngeneic sera from X-irradiated C57BL
mice given 865 r 3 days prior to bleeding, or pooled
syngeneic sera from normal C57BL mice. The treatment sera
usedwere diluted 1:4 (v/v) with RPMI-1640.
Relative spleen weights were calculated according to
Simonsen (1) ten days after injection.
Standard deviation.
Spleen index calculated according to Simonsen (1).
DISCUSSION
The results of this study indicate that; (i) allogeneic
spleen cells induce a GVHR, but allogeneic bone marrow cells
do not; (ii) treatment of mice with cortisone does not in-
fluence the ability of their spleen cells or bone marrow
cells to induce a GVHR; and (iii) treatment with serum from
lethally X-irradiated mice does not confer upon syngeneic
bone marrow cells the ability to induce a GVHR.
The mortality assay for a GVHR is the most definite,
but not the most sensitive. Various death rates among
various combinations of strains have been found which bring
out the fact that crossing major histocompatibility loci
will greatly influence the death rate (1,2).
From the results obtained with the mortality experi-
ment and from knowing the mechanism involved in a GVHR in
the test system used here, one can state two things: (i)
parental spleen cells contain many immunocompetent cells
which recognize the cells of the immunotolerant F1 hybrid
host as foreign, and produce a GVHR resulting in death and
(ii) that bone marrow does not have as many or any immuno-
competent cells capable of producing a GVHR as the spleen does.
The results of the mortality experiment are in agree-
ment with others which show that when parental C3H bone





mortality occurred, but when parental C3H spleen cells were
injected into F1 hybrids there was mortality reported at all
doses tested (1,8). This type of an experiment will reveal
only severe GVHR. There are many assay methods which are
more sensitive, such as weight gain assay (19), liver assay
(1), and phagocytic assay (4). The major assay method which
is utilized by many experimenters is the discriminant spleen
weight assay be Simonsen (1). This assay method detects
minor GVHR in the form of splenomegaly (1).
The experiments show that parental spleen cells contain
cells able to produce a lethal GVHR and that parental bone
marrow is unable to produce even a minor GVHR. These results
provide possible evidence that normal bone marrow does not
contain cells capable f ounting a GVHR. Others have
found GVHR potential to be very high in the spleen and non-
existent in the bone marrow when grafted into normal F1
hybrids (1,2,4-9,20). However, X-irradiated animals grafted
with bone marrow show signs of undergoing a GVHR, sometimes
resulting in death of the host (2,21-25). This difference
between the results obtained with bone marrow in the normal
or X-irradiated host systems could be a result of environmen-
tal control by the host on the differentiation of the bone
marrow. The difference in these results can De possibly
explained by the following theory.
Some experimenters have found that bone marrow con-
tains very few immunocompetent cells, but is a major source
of potentially immunocompetent cells in the form of precursor
16
cells which mature into immunocompetent cells in the thymus
(26-28). In the bone marrow there exists many uncommitted
stem cells each of which has four options of differentiation
into either a lymphoid cell, megakaryocyte, granulocyte, or
erythrocyte. This uncommitted stem cell is triggered to
become a committed stem cell by an "alerting factor" and a
specific poietic factor. The committed stem cell, upon con-
tact with a high concentration of the specific poietic
factor, will produce an effector cell. Each effector cell,
be it erythrocyte, platelet, immunocyte, granulocyte, or
monocyte, will release the alerting factor upon cell destruc-
tion or when involved in immune reactions and the cycle be-
gins once more. The resulting mitotic divisions of the
uncommitted stem cells will produce the effector cells of
the immunocyte line which will lodge in various secondary
sites such as the spleen, lymph nodes and, to a strain-
dependent degree, in the bone marrow. This means that when
a suspension of normal parental spleen cells, which contains
thymus-dependent immunocytes capable of inducing a GVHR, is
injected into a normal F
I 
hybrid less than 10 days old a
GVHR will occur. It is these thymus-dependent cells (T cells)
which will recognize the antigens of the F1 hybrid as foreign
and initiate the GVHR. On the other hand, when parental
bone marrow cells, which the experiments show are incapable
of mounting a GVHR, are injected into a normal F1 hybrid,
they fail to initiate the response because the bone marrow
lacks T cells. This may not be true for all strains of
17
mice, because it s been reported that within some strains
of mice various degrees of GVHR were caused by normal bone
marrow cells (18). This may be attributed to the idea that
each strain of mice will harbor a different concentration
of T cells in the bone marrow.
The difference between normal and irradiated animals
reported from the experiment of others could be due to the
presence of the "alerting factor" being released in the
irradiated effector cells. The "alerting factor" stimulates
the uncommitted stem cell in the grafted bone marrow to
differentiate into effector T cells capable of inducing a
GVHR. In the normal F
1 
hybrid there is no massive release
of the "alerting factor," nor is there need for it, so there
is no massive stem cell differentiation into T cells.
It was shown that an injection of plasma into mice may
induce a ten-fold increase in the number of endogenous colony
forming units (CFU) in the spleen, but does not increase the
number of CFU in the transplantation method (29,30). These
experiments indicate the presence of a factor in the plasma,
possibly the "alerting factor," which induces proliferation
of hematopoietic precursors from the bone marrow, as detected
by the CFU assay, and indicate a difference in the en-
vironmental conditions much like the difference between the
normal F1 hybrid and irradiated host.
The results show that simple incubation of C57BL mouse
bone marrow with serum from the irradiated C57BL mice prior
to grafting did not induce the bone marrow to induce a GVHR
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when grafted into F1 hybrids. This does not mean that the
"alerting factor" does not exist in the serum from irradiated
mice but that under the present conditions the factor did not
express its function. Possibly stricter incubation condi-
tions are needed, or the addition of thymic extracts is
needed. Both of these factors will be considered in future
work.
All the major points of a GVHR have been met in these
experiments because the direction the antigenic stimulus
was from parental cells into the F
1 
hybrids, a major histo-
compatibility locus was crossed in that the parents of the
F
1 
hybrids were of different H-2 loci, and the immunocompe-
tent parental cells were able to recognize the immunoimcompe-
tent F
1 
hybrid host as foreign and produce a GVHR. Another
major requirement was the age of the host. F
1 
hybrids are
most often used in GVHR experiments because they can be used
as recipients 10 to 14 days after birth while other random
imcompatible lines usually have only a one-day limit (31).
Others have reported that the recipient F1 will lose its
GVHR potential as it increases with age (1,2), whereas it has
been shown that GVHR potential is present in 130-week-old
recipients (32). These experimenters demonstrated the possible
correlation of GVHR potential to age of the recipients by show-
ing that young and old recipients are capable of undergoing a
GVHR because of the inadequacy of their immune systems (1,32).
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The experiments presented in this work show that normal
or cortisone-treated spleen cells failed to induce a GVHR
in normal F
1 
hybrids 26 to 27 days old, and the results of
Table 2 also show a continual decrease in the average RSW
obtained with parental spleen cells from both normal and
cortisone-treated donors as the age of the F1 hybrids in-
creased. However, others have shown that both spleen cells
from cortisone-treated donors (18) and normal donors (1,2,
3-9,20) are capable of inducing a GVHR in mice. This may
indicate that this type of F
1 
hybrid older than 3 weeks
is not a suitable host for a GVHR, but further tests are
needed to verify this point.
Cortisone treatment of donors failed to induce parental
bone marrow to provoke a GVHR in any age Fi hybrid. This
failure could be a result of the failure of cortisone to
enter the system, as deposits of cortisone were noted in the
peritoneal cavity at the site of the injection. However, a
loss of cellularity of the spleen was seen in all mice that
were given injections of cortisone.
It has been reported by other researchers that cortisone
treatment of donors did induce bone marrow to give a GVHR,
but only in one set of A/J mice was the spleen index over
1.30 (18). Their results showed that the cortisone-treated
bone marrow cells induced a significantly different spleen
index than did normal bone marrow. Their explanation for this
reaction was that cortisone treatment induced GVHR-inducing
cells to migrate from the spleen to the bone marrow (18).
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The overall results show that cortisone treatment of
C57BL donors did not destroy the ability of spleen cells
to induce a GVHR if given to a normal F1 hybrid recipient
capable of mounting a GVHR, and bone marrow from cortisone-
treated C57BL mice did not induce a GVHR in F1 
hybrids. As
a result it seems evident that cortisone is not an agent
responsible for the stem cell differentiation.
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